Trial intelligence / Profile preview

ACCESS: Crinone vs Combination for Luteal Phase Support

NCT03858049Phase 4Terminated

Sponsor
Merck KGaA
Start
May 2019
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Crinone in infertility, sponsored by Merck KGaA. Started May 2019; status: terminated.

02

Drugs

Crinone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03858049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03858049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call